Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease

The regenerative capacity of an adult cardiac tissue is insufficient to repair the massive loss of heart tissue, particularly cardiomyocytes (CMs), following ischemia or other catastrophic myocardial injuries. The delivery methods of therapeutics agents, such as small molecules, growth factors, exos...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Chengming, Joshi, Jyotsna, Li, Fan, Xu, Bing, Khan, Mahmood, Yang, Jinfu, Zhu, Wuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326780/
https://www.ncbi.nlm.nih.gov/pubmed/32671049
http://dx.doi.org/10.3389/fbioe.2020.00687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326780/
https://www.ncbi.nlm.nih.gov/pubmed/32671049
http://dx.doi.org/10.3389/fbioe.2020.00687

Ejemplares similares